Motif Bio, which is developing novel antibiotics effective against multi-drug resistant bacteria, filed on Wednesday with the SEC to raise up to $40 million in an initial public offering. The company ...
Tevogen Bio files additional AI-related patent to enhance drug discovery and develops T cell therapies for infectious diseases and cancers. Tevogen Bio, a clinical-stage biotech company specializing ...
BALTIMORE, Jan. 12, 2026 /PRNewswire/ -- IndyGeneUS Bio today announced the filing of a patent application covering its Clinico-Genomic Insight Engine™ (CGIE™)—a foundational platform under ...
Gritstone bio (NASDAQ:GRTS) has filed for Chapter 11 bankruptcy protection in Delaware, according to a court filing. The California-based biotech intends to use the court-administered restructuring ...
MIAMI BEACH, Fla., July 26, 2024 /PRNewswire/ -- Immorta Bio Inc, a science-based longevity company dedicated to treating "Diseases of Aging and Aging as a Disease™" with personalized cellular ...
WILSON, N.C.--(BUSINESS WIRE)--Averix Bio today announces its submission of a Drug Master File (DMF) to the US Food & Drug Administration (FDA) for cannabidiol (CBD) isolate. Unlike most manufacturers ...
Local life science startup Boundless Bio filed Wednesday to go public — the first San Diego biotech to do so this year. It is the first initial public offering, or IPO, by a local life science firm in ...
James M. Wilson, MD, PhD, director of the Gene Therapy Program at the University of Pennsylvania, and a co-founder of Passage Bio. Passage Bio, a developer of gene therapies for rare monogenic CNS ...
GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, a clinical-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results